Wells Fargo
AHCO icon

Wells Fargo’s AdaptHealth AHCO Stock Holding History

Wells Fargo’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$943K Buy
90,459
+51,615
+133% +$576K ﹤0.01% 4152
2026
Q1 		$462K Sell
38,844
-75,605
-66% -$774K ﹤0.01% 4219
2025
Q4 		$1.14M Buy
114,449
+35,954
+46% +$343K ﹤0.01% 3866
2025
Q3 		$703K Buy
78,495
+19,084
+32% +$177K ﹤0.01% 4063
2025
Q2 		$560K Buy
59,411
+3,635
+7% +$32.1K ﹤0.01% 4059
2025
Q1 		$605K Buy
55,776
+1,230
+2% +$12.4K ﹤0.01% 3962
2024
Q4 		$519K Buy
54,546
+14,460
+36% +$146K ﹤0.01% 4160
2024
Q3 		$450K Buy
40,086
+597
+2% +$6.34K ﹤0.01% 4064
2024
Q2 		$395K Buy
39,489
+7,804
+25% +$79.3K ﹤0.01% 4059
2024
Q1 		$365K Buy
31,685
+4,022
+15% +$34.2K ﹤0.01% 4092
2023
Q4 		$202K Buy
27,663
+1,344
+5% +$10.6K ﹤0.01% 4463
2023
Q3 		$240K Sell
26,319
-41,482
-61% -$497K ﹤0.01% 4238
2023
Q2 		$825K Buy
67,801
+38,020
+128% +$424K ﹤0.01% 3599
2023
Q1 		$370K Buy
29,781
+14,858
+100% +$273K ﹤0.01% 4044
2022
Q4 		$287K Buy
14,923
+2,227
+18% +$47.1K ﹤0.01% 3979
2022
Q3 		$239K Buy
12,696
+3,645
+40% +$74.9K ﹤0.01% 4138
2022
Q2 		$164K Sell
9,051
-15,924
-64% -$259K ﹤0.01% 4383
2022
Q1 		$400K Sell
24,975
-17,098
-41% -$307K ﹤0.01% 4567
2021
Q4 		$1.03M Sell
42,073
-2,905
-6% -$68.2K ﹤0.01% 4081
2021
Q3 		$1.05M Buy
44,978
+40,055
+814% +$969K ﹤0.01% 4197
2021
Q2 		$135K Sell
4,923
-170,827
-97% -$4.87M ﹤0.01% 5177
2021
Q1 		$6.46M Buy
175,750
+80,759
+85% +$2.85M ﹤0.01% 2590
2020
Q4 		$3.57M Sell
94,991
-148,271
-61% -$4.59M ﹤0.01% 3038
2020
Q3 		$5.3M Buy
243,262
+225,879
+1,299% +$4.74M ﹤0.01% 2447
2020
Q2 		$280K Buy
+17,383
New +$291K ﹤0.01% 4703

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo's AHCO Position: Q2 2026 in Review

Wells Fargo increased its AdaptHealth (AHCO) stake by 133% in Q2 2026, buying an estimated $576K and bringing the position to 90,459 shares worth $943K. The position accounts for ﹤0.01% of the portfolio, ranked #4152.

Wells Fargo first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.46M in Q1 2021. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Wells Fargo held 90,459 shares of AdaptHealth worth $943K as of Q2 2026.
  • Wells Fargo bought 51,615 AdaptHealth shares in Q2 2026, an estimated $576K.
  • AdaptHealth made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4152 holding.
  • Wells Fargo first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • Wells Fargo's AdaptHealth position peaked at $6.46M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.